Prosecution Insights
Last updated: October 02, 2026
Application No. 18/291,368

MOTION REDUCTION IN DIAGNOSTIC IMAGING OR RADIATION THERAPY

Non-Final OA §103
Filed
Jan 23, 2024
Priority
Aug 03, 2021 — EU 21189349.0 +1 more
Examiner
JOHNSON, NICOLE F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Koninklijke Philips N.V.
OA Round
2 (Non-Final)
87%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1210 granted / 1385 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
39 currently pending
Career history
1428
Total Applications
across all art units

Statute-Specific Performance

§101
9.0%
-31.0% vs TC avg
§103
37.6%
-2.4% vs TC avg
§102
34.3%
-5.7% vs TC avg
§112
10.0%
-30.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1385 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Alder et al. (US 2008/0177280) in view of Uber et al. (WO 2016138449) and Tran (US 2020/0077892). Adler et al. teaches monitoring patient motion during medical imaging and/or radiation therapy using physiological signals and generating control signals to reduce motion artifacts and improve treatment delivery; [0096]-[0099]. Uber et al. teaches acquiring physiological measurements including EEG measurements from a patient during imaging procedures; [0070]-[0071], [0087]-[0088]. Tran teaches determining a readiness potential (RP) from EEG signals; [0350]. It would have been obvious to one having ordinary skill in the art at the time the invention was made to the EEG-based readiness potential measurements taught by Tran as the physiological signal input of Adler et al. because Alder et al. is directed to predicting and compensating for patient motion during imaging and radiation therapy, and Tran teaches that the readiness potentials may be derived from EEG signals. Substituting one known physiological signal source for another known physiological signal source suitable for anticipating patient movement would have represented a predictable use of prior art elements according to their established functions and provide the predictable results pertaining to improving the prediction of impending patient motion and thereby improve motion compensation during imaging and radiation therapy. Response to Arguments Applicant's arguments filed April 14, 2026 have been fully considered but they are not persuasive. The applicant argues the following points in which the examiner provides a reason(s) as to why the arguments are not persuasive: The applicant argues that neither Adler et al. nor Uber et al. teaches determining a readiness potential (RP) from an EEG signal or predicting imminent voluntary motion based on the EEG signal. The argument is not persuasive. Tran expressly teaches readiness potential measurement from EEG signals; [0350]. Adler et al. teaches utilizing physiological signals to predict patient motion and generate control signals for controlling imaging and radiation therapy operations based upon the predicted motion; [0096]-[0099]. Thus, the combination teaches both determining an RP from an EEG signal and utilizing physiological information to predict patient motion. The applicant further argues that Uber et al. merely lists EEG as a measurable physiological parameter and does not teach using EEG to predict patient motion. The examiner agrees that Uber et al. does not expressly teach readiness protocol determination or motion prediction from EEG. However, these teachings are supplied by Tran and Adler et al., respectively. The rejection relies upon the combined teachings of the references rather than Uber et al. alone. Therefore, the arguments have been fully considered but are not persuasive. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Jan 23, 2024
Application Filed
Jan 09, 2026
Non-Final Rejection mailed — §103
Apr 14, 2026
Response Filed
Jun 10, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734362
METHOD AND APPARATUS FOR DETERMINING TRUE NEURAL ACTIVATION CHANGES
2y 11m to grant Granted Sep 15, 2026
Patent 12728277
DISPLAY FOR DUAL-MODE MEDICAL DEVICE
4y 6m to grant Granted Sep 08, 2026
Patent 12727811
MONITORING DIAPHRAGMATIC RESPONSE TO PHRENIC NERVE STIMULATION
2y 7m to grant Granted Sep 08, 2026
Patent 12727815
METHOD FOR MONITORING SLEEP, APPARATUS, DEVICE, AND STORAGE MEDIUM
3y 1m to grant Granted Sep 08, 2026
Patent 12714362
FUNDAMENTAL CODE UNIT OF THE BRAIN: TOWARDS A NEW MODEL FOR COGNITIVE GEOMETRY
2y 6m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
87%
Grant Probability
94%
With Interview (+7.0%)
2y 8m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1385 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month